Angelia J., Weng X., Solomatov A., Chin C., Fernandez A., Hudson P.K., Morisseau C., Hammock B.D., Kandasamy R., Pecic S. (2023). Structure-activity relationship studies of benzothiazole-phenyl analogs as multi-target ligands to alleviate pain without affecting normal behavior. Prostaglandins and Other Lipid Mediators,PMID: 36529320
2022
Rodriguez C.E.B., Ouyang L., Kandasamy R. (2022). Antinociceptive effects of minor cannabinoids, terpenes, and flavonoids in Cannabis.Behavioural Pharmacology, 33, 130-157. PMID: 33709984
2021
Wilt S., Kodani S., Valencia L., Hudson P.K., Sanchez S., Quintana T., Morisseau C., Hammock B.D., Kandasamy R., Pecic SC. (2021). Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors. Bioorganic & Medicinal Chemistry, 51, 116507. PMID: 34794001
Kandasamy R., Hillhouse T.M., Livingston K.E., Kochan K.E., Meurice C., Eans. S.O., Li M., White A.D., Roques B.P., McLaughlin J.P., Ingram S.L., Burford N.T., Alt A., Traynor J.R. (2021). Positive allosteric modulation of the mu-opioid receptor produces analgesia with reduced side-effects. Proceedings of the National Academy of Sciences, 118(16), e2000017118. PMID: 33846420
Kandasamy R. and Morgan M.M. (2021). “Reinventing the wheel” to advance the development of pain therapeutics. Behavioural Pharmacology, 32(2&3), 142-152. PMID: 33079736
2020
Senese N.B., Kandasamy R., Kochan K.E., Traynor J.R. (2020). Regulator of G-protein signaling (RGS) protein modulation of opioid receptor signaling as a potential target for pain management. Frontiers in Molecular Neuroscience, 13:5. PMID: 32038168
2018
Stanczyk M.A. and Kandasamy R. (2018). Biased agonism: The quest for the analgesic holy grail. PAIN Reports, 3(3), e650. PMID: 29922742
Kandasamy R., Dawson C.T.UG, Hilgendorf T.N.UG, Morgan M.M. (2018). Medication overuse headache following repeated morphine, but not ∆9-tetrahydrocannabinol administration in the female rat. Behavioural Pharmacology,29(5), 469-472. PMID: 29462111 Kandasamy R., Dawson C.T.UG, Craft, R.M., Morgan M.M. (2018). Anti-migraine effect of ∆9-tetrahydrocannabinol in the female rat. European Journal of Pharmacology, 818, 271-277. PMID: 29111112
2017
Kandasamy R., Lee A.T.F,, Morgan M.M. (2017). Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain. Pharmacology, Biochemistry and Behavior, 156, 10-15. PMID: 28366799
Kandasamy R., Lee A.T., Morgan M.M. (2017). Depression of home cage wheel running: a reliable and clinically relevant method to assess migraine pain in rats. The Journal of Headache and Pain, 18(1):5, 1-8. PMID: 28091820
Kandasamy R., Calsbeek J.J., Morgan M.M. (2017). Analysis of inflammation-induced depression of home cage wheel running in rats reveals the difference between opioid antinociception and restoration of function. Behavioural Brain Research, 317, 502-507. PMID: 27746208
2016
Kandasamy R., Calsbeek J.J.UG, Morgan M.M. (2016). Home cage wheel running is an objective and clinically relevant method to assess inflammatory pain in male and female rats. Journal of Neuroscience Methods, 263, 115-122.PMID: 26891874
2015
Kandasamy R. and Price T.J. (2015). The pharmacology of nociceptor priming. In Pain Control (Handbook of Experimental Pharmacology) pp. 15-37. Ed. H-G Schaible, Springer Berlin Heidelberg. PMID: 25846612
2013
Craft R.M., Kandasamy R., Davis S.M. (2013). Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat. PAIN, 154(9), 1709-1717. PMID: 23707295